Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.
Mestre G, Garcia F, Martinez E, Milinkovic A, Lopez A, León A, Mora B, Argelich R, Lozano JM, Peña J, Gatell JM, Plana M. Mestre G, et al. Among authors: mora b. AIDS Res Hum Retroviruses. 2008 Dec;24(12):1485-95. doi: 10.1089/aid.2008.0135. AIDS Res Hum Retroviruses. 2008. PMID: 19025397 Clinical Trial.
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.
León A, Martinez E, Milinkovic A, Mora B, Mallolas J, Blanco JL, Larrousse M, Laguno M, Gallart T, Plana M, Gatell JM, Garcia F. León A, et al. Among authors: mora b. J Antimicrob Chemother. 2009 Jan;63(1):184-8. doi: 10.1093/jac/dkn461. Epub 2008 Nov 11. J Antimicrob Chemother. 2009. PMID: 19001447
Medical eponyms: time for a name change.
Mora B, Bosch X. Mora B, et al. Arch Intern Med. 2010 Sep 13;170(16):1499-500. doi: 10.1001/archinternmed.2010.281. Arch Intern Med. 2010. PMID: 20837838 No abstract available.
Prognostic and Predictive Models in Myelofibrosis.
Mora B, Bucelli C, Cattaneo D, Bellani V, Versino F, Barbullushi K, Fracchiolla N, Iurlo A, Passamonti F. Mora B, et al. Curr Hematol Malig Rep. 2024 Oct;19(5):223-235. doi: 10.1007/s11899-024-00739-6. Epub 2024 Aug 24. Curr Hematol Malig Rep. 2024. PMID: 39179882 Free PMC article. Review.
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms.
Carretta C, Parenti S, Bertesi M, Rontauroli S, Badii F, Tavernari L, Genovese E, Malerba M, Papa E, Sperduti S, Enzo E, Mirabile M, Pedrazzi F, Neroni A, Tombari C, Mora B, Maffioli M, Mondini M, Brociner M, Maccaferri M, Tenedini E, Martinelli S, Bartalucci N, Bianchi E, Casarini L, Potenza L, Luppi M, Tagliafico E, Guglielmelli P, Simoni M, Passamonti F, Norfo R, Vannucchi AM, Manfredini R; MYNERVA (Myeloid NEoplasms Research Venture AIRC). Carretta C, et al. Among authors: mora b. Leukemia. 2024 Oct;38(10):2171-2182. doi: 10.1038/s41375-024-02373-w. Epub 2024 Aug 23. Leukemia. 2024. PMID: 39179669 Free PMC article.
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosis.
Tefferi A, Barosi G, Passamonti F, Hernandez-Boluda JC, Bose P, Döhner K, Ellis M, Gangat N, Garcia JS, Gisslinger H, Gotlib J, Guglielmelli P, Gupta V, Harrison C, Hexner EO, Hobbs GS, Kiladjian JJ, Koschmieder S, Kroger N, Kuykendall AT, Loscocco GG, Mascarenhas J, Masarova L, Mesa R, Mora B, Odenike O, Oh ST, Pardanani A, Patel A, Pemmaraju N, Rambaldi A, Rampal R, Sirhan S, Szuber N, Talpaz M, Vachhani PJ, Vannucchi AM, Barbui T. Tefferi A, et al. Among authors: mora b. Blood. 2024 Oct 24;144(17):1813-1820. doi: 10.1182/blood.2024025802. Blood. 2024. PMID: 39116296
253 results